Product Name: 3-Fucosyllactose
Other Name: 3-Fucosyllactose (3FL); 3-FL;
CAS No.: 41312-47-4
Chemical Structure:

3-Fucosyllactose Application:
3-Fucosyllactose (3-FL) is a human milk oligosaccharide (HMO) composed of fucose, galactose, and glucose. Naturally present in human breast milk, 3-Fucosyllactose plays an important role in supporting infant nutrition and gut microbiota development. In industrial applications, it is produced through fermentation or enzymatic synthesis to ensure high purity and consistent quality for large-scale use.
3-Fucosyllactose is a valuable ingredient in infant nutrition, dietary supplements, and functional food formulations, as well as in microbiome and biomedical research. Its growing demand reflects its importance in developing next-generation nutritional products. Applications:
Infant Nutrition & Formula Fortification
3-Fucosyllactose is widely used as an ingredient in infant formula to replicate the composition of human breast milk. It supports gut microbiota balance, immune development, and overall infant health, making it a key functional additive for early-life nutrition.Functional Foods & Dietary Supplements
Incorporated into health products targeted at various age groups, 3-Fucosyllactose contributes to digestive health and prebiotic support. It enhances the value of formulations such as fortified beverages, powders, and dietary supplements designed for wellness markets.Biotechnology & Microbiome Research
As a bioactive oligosaccharide, 3-Fucosyllactose is applied in gut microbiota and biomedical studies. It helps researchers explore host–microbe interactions and develop new therapeutic or preventive strategies related to nutrition and gastrointestinal health.
3-Fucosyllactose Packaging and Shipping:
Packaging: 1kg/ bag, 25kg/ drum or as customer’s required.
Shipping : DHL/ FedEx/ Air shipping/ Ocean shipping
3-Fucosyllactose Storage:
Store in Dry and Ventilated place with the Room Temperature, Preserved in Original Tight-Closed containers, Keep Away from Light and Heating.

